These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37371608)

  • 21. The Significance of Matrix Metalloproteinases in Oral Diseases.
    Maciejczyk M; Pietrzykowska A; Zalewska A; Knaś M; Daniszewska I
    Adv Clin Exp Med; 2016; 25(2):383-90. PubMed ID: 27627574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DENTINE CARIES: ACID-TOLERANT MICROORGANISMS AND ASPECTS ON COLLAGEN DEGRADATION.
    Lager AH
    Swed Dent J Suppl; 2014; (233):9-94. PubMed ID: 26688982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
    Liu J; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients.
    Ingman T; Tervahartiala T; Ding Y; Tschesche H; Haerian A; Kinane DF; Konttinen YT; Sorsa T
    J Clin Periodontol; 1996 Dec; 23(12):1127-32. PubMed ID: 8997658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases in lung diseases.
    Ohbayashi H
    Curr Protein Pept Sci; 2002 Aug; 3(4):409-21. PubMed ID: 12370004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
    Stracke JO; Fosang AJ; Last K; Mercuri FA; Pendás AM; Llano E; Perris R; Di Cesare PE; Murphy G; Knäuper V
    FEBS Lett; 2000 Jul; 478(1-2):52-6. PubMed ID: 10922468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staphylococcal Superantigen-Like Protein 1 and 5 (SSL1 & SSL5) Limit Neutrophil Chemotaxis and Migration through MMP-Inhibition.
    Koymans KJ; Bisschop A; Vughs MM; van Kessel KP; de Haas CJ; van Strijp JA
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue inhibitors of metalloproteinases (TIMPs): their biological functions and involvement in oral disease.
    Verstappen J; Von den Hoff JW
    J Dent Res; 2006 Dec; 85(12):1074-84. PubMed ID: 17122157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of matrix metalloproteinases (MMPs) in human caries.
    Chaussain-Miller C; Fioretti F; Goldberg M; Menashi S
    J Dent Res; 2006 Jan; 85(1):22-32. PubMed ID: 16373676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of collagenase-1 (MMP-1), collagenase-3 (MMP-13) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in laryngeal squamous cell carcinomas.
    Krecicki T; Fraczek M; Jelen M; Podhorska M; Szkudlarek T; Zatonski T
    Eur Arch Otorhinolaryngol; 2003 Oct; 260(9):494-7. PubMed ID: 12739032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laminin-5 gamma2-chain and collagenase-2 (MMP-8) in human peri-implant sulcular fluid.
    Kivelä-Rajamäki MJ; Teronen OP; Maisi P; Husa V; Tervahartiala TI; Pirilä EM; Salo TA; Mellanen L; Sorsa TA
    Clin Oral Implants Res; 2003 Apr; 14(2):158-65. PubMed ID: 12656874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions.
    Tjäderhane L; Larjava H; Sorsa T; Uitto VJ; Larmas M; Salo T
    J Dent Res; 1998 Aug; 77(8):1622-9. PubMed ID: 9719036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix metalloproteinases (MMP-1, -8, -13) in chronic periapical lesions.
    Andonovska B; Dimova C; Panov S
    Vojnosanit Pregl; 2008 Dec; 65(12):882-6. PubMed ID: 19160981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis.
    Kuula H; Salo T; Pirilä E; Hagström J; Luomanen M; Gutierrez-Fernandez A; Romanos GE; Sorsa T
    Arch Oral Biol; 2008 Feb; 53(2):175-86. PubMed ID: 17996844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of extracellular matrix metalloproteinase inducer glycosylation in regulating matrix metalloproteinases in periodontitis.
    Zhang Z; Yang X; Zhang H; Liu X; Pan S; Li C
    J Periodontal Res; 2018 Jun; 53(3):391-402. PubMed ID: 29315565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.
    Benjamin MM; Khalil RA
    Exp Suppl; 2012; 103():209-79. PubMed ID: 22642194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
    Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
    J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-13 (MMP-13, collagenase-3) is highly expressed in human tooth pulp.
    Sulkala M; Pääkkönen V; Larmas M; Salo T; Tjäderhane L
    Connect Tissue Res; 2004; 45(4-5):231-7. PubMed ID: 15763932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
    Cells; 2020 May; 9(5):. PubMed ID: 32466129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.